INCOME TAXES
For the years ended December 31, 2025, 2024 and 2023 income before income taxes included the following components:
Year Ended December 31,
202520242023
Domestic$167,873 $97,051 $16,501 
Foreign14,537 5,255 1,276 
Total$182,410 $102,306 $17,777 
For the years ended December 31, 2025, 2024 and 2023 the Company recognized the following provision for income taxes:
Twelve months ended December 31,
202520242023
Current:
Federal$(6,243)$10,652 $895 
State(313)2,639 607 
Foreign1,630 284 341 
Total$(4,926)$13,575 $1,843 
Deferred:
Federal$(207,587)$— $— 
State$(17,556)— — 
Foreign$(1,586)157 (133)
Total$(226,729)$157 $(133)
(Benefit from) provision for income taxes$(231,655)$13,732 $1,710 
Upon adoption of ASU 2023-09, Improvements to Income Tax Disclosures, as described in Note 2, “Summary of Significant Accounting Policies”, cash paid for taxes, net of refunds, during the year ended December 31, 2025 was as follows:
Federal
$9,700 
State
3,955 
Foreign
702 
Total cash paid for income taxes, net of refunds
$14,357 
Cash paid for income taxes, net of refunds, during the years ended December 31, 2024 and 2023 was $7,620 and $2,320, respectively.
Upon adoption of ASU 2023-09, Improvements to Income Tax Disclosures, as described in Note 2, “Summary of Significant Accounting Policies”, the reconciliation of taxes at the federal statutory rate to our benefit from income taxes for the year ended December 31, 2025 was as follows:
Amount
Percent
Expected income tax expense at federal statutory rate$38,306 21.0 %
State taxes, net of Federal income tax effect (1)(17,799)(9.8)%
Foreign tax effects
Inducement payment(2,651)(1.5)%
Other920 0.5 %
Foreign-Derived Intangible Income deduction6,426 3.5 %
Research and development credit8,360 4.6 %
Valuation allowance changes(233,479)(128.0)%
Nontaxable or nondeductible items:
Equity compensation(81,847)(44.9)%
Section 162(m) limitation47,050 25.8 %
Meals and entertainment2,900 1.6 %
Other159 0.1 %
Effective income tax rate(231,655)(127.0)%
________________
(1) State taxes in California, Pennsylvania and Illinois made up the majority (greater than 50 percent) of the tax effect in this category.

The reconciliation of taxes at the federal statutory rate to our provision for taxes for the years ended December 31, 2024 and 2023 in accordance with the guidance prior to the adoption of ASU 2023-09 was as follows:
20242023
Expected income tax expense at federal statutory rate
21.0 %21.0 %
State taxes, net of Federal income tax effect
(3.8)(35.1)
Section 162(m) limitation58.1 56.5 
Equity compensation
(97.9)(208.4)
Meals and entertainment
1.2 5.6 
Foreign-Derived Intangible Income deduction
(13.5)(13.4)
Other permanent adjustments
1.8 2.2 
Research and development credit
(23.5)(76.4)
Valuation allowance
70.0 257.6 
Effective income tax rate
13.4 %9.6 %
The 2025 and 2024 effective tax rate differs from the statutory rate primarily due to tax-deductible stock-based compensation and the generation of research and development tax credits. The effective tax rate for 2025 is also significantly impacted by the release of the valuation allowance on the Company’s net deferred tax assets, while the effective tax rate for 2024 reflects changes in the valuation allowance.
The Company has the following deferred tax assets (liabilities) as of December 31, 2025 and 2024:
20252024
Net operating loss carryforwards$27,541 $4,491 
Section 174 research and development capitalization118,009 190,768 
Research and development credits74,943 61,198 
Lease liability22,201 13,004 
Stock-based compensation6,881 4,755 
Marketing and advertising1,124 674 
Sales tax / Value added tax ("VAT") reserve905 560 
Other deferred tax assets516 70 
Valuation allowance— (256,728)
Total deferred tax assets252,120 18,792 
ROU asset(17,551)(10,757)
Capitalized software(4,251)(4,444)
Property and equipment(2,440)(2,885)
Other deferred tax liabilities(788)(322)
Total deferred tax liabilities(25,030)(18,408)
Net deferred taxes$227,090 $384 
During the year ended December 31, 2025, the Company released the valuation allowance previously recorded against its federal and state DTAs, resulting in a one-time income-tax benefit of $256,728. In reaching this conclusion, management considered, among other factors, consecutive quarterly pre-tax profitability, a three-year cumulative income position, and sustained operational profitability. Management will continue to monitor quarterly operating results, projected taxable income, and other relevant evidence, and may record a valuation allowance in future periods if actual results or other information differ from current expectations.
The income-tax benefit for the year ended December 31, 2025 reflects the combined impact of the valuation-allowance release and other discrete tax items recognized during the period, which are not indicative of ongoing operating performance. The decision to release the valuation allowance was based primarily on sustained and verifiable positive evidence.
As of December 31, 2025, the company has accumulated undistributed earnings generated by our foreign subsidiaries, most of which have been previously subject to U.S. tax. We intend to indefinitely reinvest these earnings, as well as future earnings from our foreign subsidiaries to fund our international operations. In addition, we expect future U.S. cash generation will be sufficient to meet future U.S. cash needs.
On July 4, 2025, the One Big Beautiful Bill Act was signed into law. Included in this legislation are provisions that allow for the immediate expensing of domestic research and development expenses, which the Company implemented during 2025. These changes did not have a material impact to the overall financial statements the year ended December 31, 2025.
The Company’s income before taxes, income tax provision or benefit and effective tax rates were as follows. The large variance in the effective tax rate between periods primarily reflects the recognition of the valuation-allowance release and other discrete tax benefits in the year ended December 31, 2025.
The following table represents the activity in our valuation allowance for the years ended December 31, 2025 and 2024:
Year Ended December 31,
20252024
Beginning balance—January 1$(256,728)$(156,870)
Increase in valuation allowance — (99,858)
Release of valuation allowances256,728 — 
Ending balance—December 31$— $(256,728)
The Company utilized its remaining federal net operating loss carryforwards in 2024, but during 2025 generated $111,199 of federal net operating losses, with an indefinite carryforward. The Company also has approximately $72,425 in state net operating loss carryforwards. State net operating loss carryforwards are subject to varying statutory carryforward periods, generally ranging from 10 to 30 years, with certain jurisdictions permitting indefinite carryforward. As of December 31, 2025,these state net operating loss carryforwards will begin to expire in 2035 and continue through 2047.
The Company has approximately $76,419 in federal and state general business credits that are available to offset future taxable income through 2045. The Company has analyzed the impact of IRC Sections 382 and 383 on these tax attributes and has determined that no prior ownership changes have occurred which would limit the Company’s ability to utilize the NOLs and research and development tax credits.
The Company’s tax years through the 2025 tax year remain subject to examination by federal and state tax authorities.
The Company utilizes a more-likely-than-not standard in recognizing a tax benefit in its financial statements. No uncertain tax benefits have been recorded in 2025, 2024, and 2023, respectively.

Historical Timeline

Fiscal YearFiled
2025Feb 27, 2026Showing above
2024Feb 28, 2025
2023Feb 29, 2024
2022Mar 1, 2023
2021Mar 4, 2022

About Income Taxes Disclosures

The income tax disclosure reveals how much a company actually pays in taxes versus what the statutory rate would predict. Analysts focus on the effective tax rate (ETR) reconciliation, which breaks down every item driving the gap between the 21% federal rate and the company's reported ETR — including R&D credits, foreign rate differentials, and state taxes. Deferred tax assets (DTAs) and their valuation allowances signal management's confidence in future profitability: a rising allowance suggests the company doubts it can use accumulated tax benefits. Uncertain tax benefit (UTB) reserves quantify exposure to IRS challenges on aggressive positions.

Key signals to watch: sudden ETR drops without clear operational reasons, large increases in valuation allowances, growing UTB balances, and significant unremitted foreign earnings. Post-TCJA, pay attention to GILTI and BEAT provisions that affect multinational tax structures. Compare the cash taxes paid (from the cash flow statement) against the income tax provision to gauge earnings quality.